Meet ‘Fanzor,’ the 1st CRISPR-like system found in complex life
Scientists discovered Fanzor proteins, which work like CRISPR but are smaller and more easily delivered into cells, and used them to edit human DNA.
Related Articles
The Scientist Names CRISPR in a Box™ Among the Top 10 Innovations for 2024 – ChristianaCare News
ChristianaCare’s Gene Editing Institute’s CRISPR in a Box™ teaching toolkit has been named the #2 innovation on The Scientist’s Top 10 Innovations list for 2024.…
CRISPR News: CRISPR – A Discovery Timeline
This timeline details the key discoveries leading to the development of CRISPR-Cas9 gene editing. It highlights the contributions of numerous scientists, from the initial observation of…
Sweeter tomatoes are coming soon thanks to CRISPR gene editing
Selection for bigger tomatoes has made the fruits less sweet, but now it has been shown that gene editing can make them sweeter without decreasing…
Dr. Jennifer Doudna Talks Editing Genes and Shredding Cancer
UCSB Arts & Lectures and the Cancer Foundation of Santa Barbara host the Nobel Prize–winning biochemist for a talk on CRISPR on Tuesday at the…
Scientists Use CRISPR Tools to Safely Disable Gene Mutation Linked to Advanced Skin Cancer – ChristianaCare News
In a potential advance for melanoma patients, researchers at ChristianaCare’s Gene Editing Institute have used CRISPR gene editing tools to disable a gene mutation often…
Filament structure found to activate and regulate CRISPR-Cas ‘protein scissors’
CRISPR-Cas systems help to protect bacteria from viruses. Several different types of CRISPR-Cas defense systems are found in bacteria, which differ in their composition and…
Structure of a eukaryotic CRISPR-Cas homolog, Fanzor2, shows promise for gene editing
Scientists at St. Jude Children’s Research Hospital have revealed how Fanzor2’s divergence from bacterial ancestors may make it a useful tool for future genomic engineering…
CRISPR-Cas13: A new frontier in RNA-editing with therapeutic potential
In recent years, the scientific community has made significant strides in the field of gene editing, particularly through the development of the CRISPR (Clustered Regularly…
Structure of a eukaryotic CRISPR-Cas homolog, Fanzor2, shows promise for gene editing
Scientists at St. Jude Children’s Research Hospital have revealed how Fanzor2’s divergence from bacterial ancestors may make it a useful tool for future genomic engineering…
Canada Approves Vertex and CRISPR Therapeutics’ Gene Therapy Casgevy for Sickle Cell Disease and TDT
The approvals are indicated for patients 12 years and older.